Veru to report fiscal 2024 first quarter financial results on february 8, 2024

Miami, fl, jan. 25, 2024 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of obesity, oncology, and viral induced acute respiratory distress syndrome, today announced it will host a conference call and audio webcast on thursday, february 8, 2024, at 8:00 a.m. et to discuss its fiscal 2024 first quarter financial results and to provide a business update.
VERU Ratings Summary
VERU Quant Ranking